Published in NMR Biomed on May 30, 2016
Brain magnetic resonance imaging with contrast dependent on blood oxygenation. Proc Natl Acad Sci U S A (1990) 17.55
Intrinsic signal changes accompanying sensory stimulation: functional brain mapping with magnetic resonance imaging. Proc Natl Acad Sci U S A (1992) 14.96
Susceptibility weighted imaging (SWI). Magn Reson Med (2004) 8.58
Why do many psychiatric disorders emerge during adolescence? Nat Rev Neurosci (2008) 6.97
Undetectable intracellular free copper: the requirement of a copper chaperone for superoxide dismutase. Science (1999) 6.86
Femtomolar sensitivity of metalloregulatory proteins controlling zinc homeostasis. Science (2001) 6.81
Imaging iron stores in the brain using magnetic resonance imaging. Magn Reson Imaging (2005) 5.83
Magnetic resonance imaging of blood vessels at high fields: in vivo and in vitro measurements and image simulation. Magn Reson Med (1990) 5.28
Transition metal speciation in the cell: insights from the chemistry of metal ion receptors. Science (2003) 5.12
High-field MRI of brain cortical substructure based on signal phase. Proc Natl Acad Sci U S A (2007) 5.02
The role of magnetic susceptibility in magnetic resonance imaging: MRI magnetic compatibility of the first and second kinds. Med Phys (1996) 4.94
Susceptibility-weighted imaging: technical aspects and clinical applications, part 2. AJNR Am J Neuroradiol (2009) 4.93
The effect of age on the non-haemin iron in the human brain. J Neurochem (1958) 4.83
Theory of NMR signal behavior in magnetically inhomogeneous tissues: the static dephasing regime. Magn Reson Med (1994) 4.60
Intracranial Gadolinium Deposition after Contrast-enhanced MR Imaging. Radiology (2015) 4.36
Small vessels in the human brain: MR venography with deoxyhemoglobin as an intrinsic contrast agent. Radiology (1997) 4.13
Metalloproteins and metal sensing. Nature (2009) 3.97
Maturation of white matter in the human brain: a review of magnetic resonance studies. Brain Res Bull (2001) 3.74
Quantitative imaging of intrinsic magnetic tissue properties using MRI signal phase: an approach to in vivo brain iron metabolism? Neuroimage (2010) 3.55
Clinical applications of neuroimaging with susceptibility-weighted imaging. J Magn Reson Imaging (2005) 3.05
Magnetic susceptibility mapping of brain tissue in vivo using MRI phase data. Magn Reson Med (2009) 3.00
Susceptibility contrast in high field MRI of human brain as a function of tissue iron content. Neuroimage (2008) 2.68
Sensitivity of MRI resonance frequency to the orientation of brain tissue microstructure. Proc Natl Acad Sci U S A (2010) 2.61
MR imaging of human brain at 3.0 T: preliminary report on transverse relaxation rates and relation to estimated iron content. Radiology (1999) 2.58
Quantitative BOLD: mapping of human cerebral deoxygenated blood volume and oxygen extraction fraction: default state. Magn Reson Med (2007) 2.55
Biophysical mechanisms of phase contrast in gradient echo MRI. Proc Natl Acad Sci U S A (2009) 2.49
T2* and FSE MRI distinguishes four subtypes of neurodegeneration with brain iron accumulation. Neurology (2008) 2.38
Lipid composition of the normal human brain: gray matter, white matter, and myelin. J Lipid Res (1965) 2.35
Cortical blood vessels of the human brain. Brain Res Bull (1981) 2.34
Layer-specific variation of iron content in cerebral cortex as a source of MRI contrast. Proc Natl Acad Sci U S A (2010) 2.33
In vivo determination of intra-myocellular lipids in human muscle by means of localized 1H-MR-spectroscopy. Magn Reson Med (1997) 2.21
Susceptibility-weighted MR imaging: a review of clinical applications in children. AJNR Am J Neuroradiol (2007) 2.18
Characterizing iron deposition in multiple sclerosis lesions using susceptibility weighted imaging. J Magn Reson Imaging (2009) 2.17
Bulk magnetic susceptibility shifts in NMR studies of compartmentalized samples: use of paramagnetic reagents. Magn Reson Med (1990) 2.06
Whole-brain susceptibility mapping at high field: a comparison of multiple- and single-orientation methods. Neuroimage (2010) 2.03
A cytosolic iron chaperone that delivers iron to ferritin. Science (2008) 2.00
High-field (9.4 T) MRI of brain dysmyelination by quantitative mapping of magnetic susceptibility. Neuroimage (2011) 1.98
Manganese neurotoxicity: a review of clinical features, imaging and pathology. Neurotoxicology (1999) 1.97
MRI estimates of brain iron concentration in normal aging using quantitative susceptibility mapping. Neuroimage (2011) 1.87
Differentiation between diamagnetic and paramagnetic cerebral lesions based on magnetic susceptibility mapping. Med Phys (2010) 1.87
Assessment of relative brain iron concentrations using T2-weighted and T2*-weighted MRI at 3 Tesla. Magn Reson Med (1994) 1.85
Magnetic susceptibility anisotropy of human brain in vivo and its molecular underpinnings. Neuroimage (2011) 1.85
Fiber orientation-dependent white matter contrast in gradient echo MRI. Proc Natl Acad Sci U S A (2012) 1.80
High-field magnetic resonance imaging of brain iron: birth of a biomarker? NMR Biomed (2004) 1.80
Myelinated nerve fibres in the CNS. Prog Neurobiol (1993) 1.79
Quantitative susceptibility mapping for investigating subtle susceptibility variations in the human brain. Neuroimage (2012) 1.77
MRI of brain iron. AJR Am J Roentgenol (1986) 1.76
Imaging cortical lesions in multiple sclerosis with ultra-high-field magnetic resonance imaging. Arch Neurol (2010) 1.75
Mammalian iron metabolism and its control by iron regulatory proteins. Biochim Biophys Acta (2012) 1.74
Quantitative susceptibility mapping (QSM) as a means to measure brain iron? A post mortem validation study. Neuroimage (2012) 1.74
The microvascular system of the striate and extrastriate visual cortex of the macaque. Cereb Cortex (2008) 1.71
Susceptibility-weighted imaging to visualize blood products and improve tumor contrast in the study of brain masses. J Magn Reson Imaging (2006) 1.70
The contribution of myelin to magnetic susceptibility-weighted contrasts in high-field MRI of the brain. Neuroimage (2011) 1.68
Tracking iron in multiple sclerosis: a combined imaging and histopathological study at 7 Tesla. Brain (2011) 1.68
Quantitative proteomics identifies NCOA4 as the cargo receptor mediating ferritinophagy. Nature (2014) 1.65
In vivo imaging of cortical pathology in multiple sclerosis using ultra-high field MRI. Neurology (2009) 1.64
Toward in vivo histology: a comparison of quantitative susceptibility mapping (QSM) with magnitude-, phase-, and R2*-imaging at ultra-high magnetic field strength. Neuroimage (2012) 1.60
The influence of white matter fibre orientation on MR signal phase and decay. NMR Biomed (2010) 1.60
Cellular distribution of transferrin, ferritin, and iron in normal and aged human brains. J Neurosci Res (1990) 1.60
Autophagy at the crossroads of catabolism and anabolism. Nat Rev Mol Cell Biol (2015) 1.59
A gradient in cortical pathology in multiple sclerosis by in vivo quantitative 7 T imaging. Brain (2015) 1.59
Histochemical distribution of non-haem iron in the human brain. Acta Anat (Basel) (1992) 1.58
Iron metabolism in the CNS: implications for neurodegenerative diseases. Nat Rev Neurosci (2013) 1.46
Selective VPS34 inhibitor blocks autophagy and uncovers a role for NCOA4 in ferritin degradation and iron homeostasis in vivo. Nat Cell Biol (2014) 1.46
On the role of neuronal magnetic susceptibility and structure symmetry on gradient echo MR signal formation. Magn Reson Med (2013) 1.46
High-resolution 7T MRI of the human hippocampus in vivo. J Magn Reson Imaging (2008) 1.46
On the contribution of deoxy-hemoglobin to MRI gray-white matter phase contrast at high field. Neuroimage (2009) 1.41
Health and physiological effects of human exposure to whole-body four-tesla magnetic fields during MRI. Ann N Y Acad Sci (1992) 1.40
3D fiber tractography with susceptibility tensor imaging. Neuroimage (2011) 1.39
Hyperpolarized 129Xe NMR as a probe for blood oxygenation. Magn Reson Med (2000) 1.39
T2*-based fiber orientation mapping. Neuroimage (2011) 1.37
An assessment of current brain targets for deep brain stimulation surgery with susceptibility-weighted imaging at 7 tesla. Neurosurgery (2010) 1.36
The role of iron in brain ageing and neurodegenerative disorders. Lancet Neurol (2014) 1.35
High resolution magnetic susceptibility mapping of the substantia nigra in Parkinson's disease. J Magn Reson Imaging (2011) 1.35
Magnetic resonance frequency shifts during acute MS lesion formation. Neurology (2013) 1.35
Micro-compartment specific T2* relaxation in the brain. Neuroimage (2013) 1.34
Magnetic susceptibility induced white matter MR signal frequency shifts--experimental comparison between Lorentzian sphere and generalized Lorentzian approaches. Magn Reson Med (2014) 1.33
Biophysical mechanisms of MRI signal frequency contrast in multiple sclerosis. Proc Natl Acad Sci U S A (2012) 1.32
Transverse relaxivity of particulate MRI contrast media: from theories to experiments. Magn Reson Med (1991) 1.32
Myelin and iron concentration in the human brain: a quantitative study of MRI contrast. Neuroimage (2014) 1.30
MR of hemorrhage: a new approach. AJNR Am J Neuroradiol (1986) 1.27
Fatty acyl chain order in lecithin model membranes determined from proton magnetic resonance. Biochemistry (1978) 1.26
The non-haemin iron in the cerebral cortex in Alzheimer's disease. J Neurochem (1960) 1.24
In vivo assessment of myelination by phase imaging at high magnetic field. Neuroimage (2011) 1.23
The in vivo influence of white matter fiber orientation towards B(0) on T2* in the human brain. NMR Biomed (2010) 1.22
Cerebellar cortical layers: in vivo visualization with structural high-field-strength MR imaging. Radiology (2010) 1.21
Brain iron uptake and homeostatic mechanisms: an overview. Biometals (2003) 1.21
Mapping magnetic susceptibility anisotropies of white matter in vivo in the human brain at 7 T. Neuroimage (2012) 1.21
Quantifying the local tissue volume and composition in individual brains with magnetic resonance imaging. Nat Med (2013) 1.20
Neurodegeneration with brain iron accumulation - clinical syndromes and neuroimaging. Biochim Biophys Acta (2011) 1.20
The role of advanced MR imaging findings as biomarkers of traumatic brain injury. J Head Trauma Rehabil (2010) 1.19
Activation of the HIF prolyl hydroxylase by the iron chaperones PCBP1 and PCBP2. Cell Metab (2011) 1.19
Free manganese (II) and iron (II) cations can act as intracellular cell controls. FEBS Lett (1982) 1.18
T₂* mapping and B₀ orientation-dependence at 7 T reveal cyto- and myeloarchitecture organization of the human cortex. Neuroimage (2012) 1.18
Quantitative susceptibility mapping: current status and future directions. Magn Reson Imaging (2014) 1.17
Fast multislice mapping of the myelin water fraction using multicompartment analysis of T2* decay at 3T: a preliminary postmortem study. Magn Reson Med (2007) 1.17
Susceptibility-weighted imaging and quantitative susceptibility mapping in the brain. J Magn Reson Imaging (2014) 1.16
A serial in vivo 7T magnetic resonance phase imaging study of white matter lesions in multiple sclerosis. Mult Scler (2012) 1.16
Measuring iron in the brain using quantitative susceptibility mapping and X-ray fluorescence imaging. Neuroimage (2013) 1.16
Origins of the ultrashort-T2 1H NMR signals in myelinated nerve: a direct measure of myelin content? Magn Reson Med (2011) 1.15